(Q39509248)

12 September 2017

title

C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes (English)

1 reference

12 September 2017

0 references

1 reference

F Liu

1

1 reference

12 September 2017

H Y Chen

2

1 reference

12 September 2017

X R Huang

3

1 reference

12 September 2017

A C K Chung

4

1 reference

12 September 2017

L Zhou

5

1 reference

12 September 2017

P Fu

6

1 reference

12 September 2017

A J Szalai

7

1 reference

12 September 2017

H Y Lan

8

1 reference

12 September 2017

publication date

9 July 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

54

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

2713-2723

1 reference

A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens

12 September 2017

cites work

1 reference

12 December 2020

Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.

1 reference

12 December 2020

Targeting C-reactive protein for the treatment of cardiovascular disease.

1 reference

12 December 2020

Latent TGF-beta1 protects against crescentic glomerulonephritis

1 reference

12 December 2020

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

1 reference

12 December 2020

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

1 reference

12 December 2020

Association of Low-Grade Inflammation with Nephropathy in Type 2 Diabetic Patients: Role of Elevated CRP-Levels and 2 Different Gene-Polymorphisms of Proinflammatory Cytokines

1 reference

12 December 2020

Mouse models of diabetic nephropathy

1 reference

12 December 2020

The JUPITER trial: results, controversies, and implications for prevention

1 reference

12 December 2020

Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction

1 reference

12 December 2020

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

12 December 2020

C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma receptors

1 reference

12 December 2020

Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse

1 reference

12 December 2020

C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice

1 reference

12 December 2020

NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy

1 reference

12 December 2020

C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease

1 reference

12 December 2020

C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes.

1 reference

12 December 2020

Adeno-associated virus-mediated human C-reactive protein gene delivery causes endothelial dysfunction and hypertension in rats

1 reference

12 December 2020

C-reactive protein activates the nuclear factor-kappaB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells

1 reference

12 December 2020

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

1 reference

12 December 2020

C-reactive protein and microalbuminuria in a multi-ethnic Asian population

1 reference

12 December 2020

Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications

1 reference

12 December 2020

Varied biologic functions of C-reactive protein: lessons learned from transgenic mice.

1 reference

12 December 2020

C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.

1 reference

12 December 2020

Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease

1 reference

12 December 2020

Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease

1 reference

12 December 2020

The role of inflammatory cytokines in diabetic nephropathy.

1 reference

12 December 2020

High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus

1 reference

12 December 2020

C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling.

1 reference

12 December 2020

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

1 reference

12 December 2020

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

1 reference

12 December 2020

Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.

1 reference

12 December 2020

Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity

1 reference

12 December 2020

Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein

1 reference

12 December 2020

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

1 reference

12 December 2020

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

12 December 2020

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

12 December 2020

C-reactive protein promotes monocyte chemoattractant protein-1--mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes

1 reference

12 December 2020

Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.

1 reference

12 December 2020

The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings

1 reference

12 December 2020

Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy

1 reference

12 December 2020

10.1007/S00125-011-2237-Y

Identifiers

DOI

1 reference

release_lfhu42robfbr5dkihmn5wksmdm

12 September 2017

Fatcat ID

0 references

1 reference